Posted on July 18, 20257/18/25
Bridging the Evidence Gap in Hereditary Angioedema (HAE): Indirect Comparison Highlights Garadacimab’s Potential
Posted on July 3, 20257/3/25
Staying Ahead of the Curve in Pharmacovigilance: Inspection Metrics Report for 2023 by Egyptian Drug Authority (EDA)
Posted on July 1, 20257/1/25
Staying Ahead of the Curve in Pharmacovigilance: ANVISA RDC No. 967/25
Posted on June 6, 20256/6/25
Comparing Long-Term HAE Treatments: Insights from a Robust Network Meta-Analysis
Posted on May 23, 20255/23/25
Most Favored Nation Pricing | Insights and Implications for Manufacturers
Posted on May 22, 20255/22/25
Demystifying Market Access: A Must-Read for Navigating the Lab-to-Patient Journey
Posted on May 21, 20255/21/25
EVERSANA Returns as Global Host and Presenting Sponsor for Frontiers Health 2025
Posted on May 15, 20255/15/25